FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

10 letters match. Newest first.

  1. Central Coast Multispecialty Medical Group, Inc.

    FDA warns Central Coast Multispecialty Medical Group over incomplete donor screening and eligibility for reproductive tissue.

    High risk
  2. Conceive Fertility Center

    FDA says Conceive Fertility Center in Dallas used incomplete donor screening and testing for reproductive cells.

    High risk
  3. Louisville Reproductive Center

    Louisville Reproductive Center failed to properly test and screen semen donors for infectious diseases, FDA found.

    High risk
  4. Green Valley Fertility Partners

    FDA cited Green Valley Fertility Partners for donor eligibility failures involving oocyte HCT/Ps, including missing communicable disease testing and screening.

    High risk
  5. InVia Fertility Specialists, PLLC

    FDA warned InVia Fertility Specialists over reproductive tissue donor eligibility and missing infectious disease testing.

    High risk
  6. Washington Fertility Center

    FDA warned Washington Fertility Center about incomplete donor eligibility screening and testing for oocytes, semen, and embryos.

    High risk
  7. The New Hope Center for Reproductive Medicine

    FDA warns Virginia Beach fertility center over incomplete donor screening and testing for reproductive tissue.

    High risk
  8. Mark S. Denker, M.D., PA dba Palm Beach Fertility Center

    FDA warns Boca Raton fertility center over failures to screen sperm and egg donors for infectious disease risk.

    High risk
  9. Zhang Medical P.C. dba New Hope Fertility Center

    New Hope Fertility Center failed to properly screen and test oocyte and semen donors for communicable diseases, FDA says.

    High risk
  10. Cooper Institute

    FDA warned Houston fertility clinic Cooper Institute that it failed to test and screen oocyte donors for infectious diseases.

    High risk